PRINCETON, N.J., Oct. 3 /PRNewswire-FirstCall/ -- Covance Inc.
(NYSE: CVD), one of the world's largest and most comprehensive drug
development services companies, today announced that it has closed its
transaction with Eli Lilly and Company to provide a broad-range of drug
development services over the next ten years and to purchase Lilly's 450-acre
early drug development campus in Greenfield, Indiana. Effective midnight
tonight, Covance will assume control of the Greenfield campus and 264 Lilly
employees will be working for Covance.
Covance, with headquarters in Princeton, New Jersey, is one of the world's
largest and most comprehensive drug development services companies with annual
revenues greater than $1.5 billion, global operations in more than 20
countries, and more than 9,000 employees worldwide. Information on Covance's
products and services, recent press releases, and SEC filings can be obtained
through its website at http://www.covance.com.
SOURCE Covance Inc.